These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
986 related articles for article (PubMed ID: 8980862)
41. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Espinal MA; Laserson K; Camacho M; Fusheng Z; Kim SJ; Tlali RE; Smith I; Suarez P; Antunes ML; George AG; Martin-Casabona N; Simelane P; Weyer K; Binkin N; Raviglione MC Int J Tuberc Lung Dis; 2001 Oct; 5(10):887-93. PubMed ID: 11605880 [TBL] [Abstract][Full Text] [Related]
42. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines. Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582 [TBL] [Abstract][Full Text] [Related]
43. Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants. Ward HA; Marciniuk DD; Hoeppner VH; Jones W Int J Tuberc Lung Dis; 2005 Feb; 9(2):164-9. PubMed ID: 15732735 [TBL] [Abstract][Full Text] [Related]
44. [Multidrug-resistant tuberculosis. 5. Human immunodeficiency virus infection and multidrug-resistant tuberculosis]. Fujita A Kekkaku; 1998 Nov; 73(11):679-85. PubMed ID: 9866931 [TBL] [Abstract][Full Text] [Related]
45. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012. Chang KC; Yew WW Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408 [TBL] [Abstract][Full Text] [Related]
46. Multidrug-resistant tuberculosis: long term follow-up of 40 non-HIV-infected patients. Avendaño M; Goldstein RS Can Respir J; 2000; 7(5):383-9. PubMed ID: 11058206 [TBL] [Abstract][Full Text] [Related]
48. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai. Shah I; Shah F Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119 [TBL] [Abstract][Full Text] [Related]
49. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
50. Outcome of multi-drug resistant tuberculosis cases treated by individualized regimens at a tertiary level clinic. Dhingra VK; Rajpal S; Mittal A; Hanif M Indian J Tuberc; 2008 Jan; 55(1):15-21. PubMed ID: 18361306 [TBL] [Abstract][Full Text] [Related]
51. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients]. Ye Z; Pei X; Yang Y Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811 [TBL] [Abstract][Full Text] [Related]
52. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471 [TBL] [Abstract][Full Text] [Related]
53. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus. Kam KM; Yip CW Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147 [TBL] [Abstract][Full Text] [Related]
54. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation. Abate G Ethiop Med J; 2002 Jan; 40(1):79-86. PubMed ID: 12240570 [TBL] [Abstract][Full Text] [Related]
55. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa. Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610 [TBL] [Abstract][Full Text] [Related]